Corvus Pharmaceuticals Inc
F:C17
Corvus Pharmaceuticals Inc
F:C17
Price:
9.134
EUR
0.97%
Market Closed
Market Cap:
€571.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Corvus Pharmaceuticals Inc
F:C17
|
US |
|
T
|
Tokushu Tokai Paper Co Ltd
TSE:3708
|
JP |
|
P
|
Pitney Bowes Inc
SWB:PBW
|
US |
|
I
|
Iovance Biotherapeutics Inc
SWB:2LB
|
US |
|
M3 Inc
F:4YC
|
JP |
|
Banca Mediolanum SpA
F:ME1
|
IT |
|
Allogene Therapeutics Inc
NASDAQ:ALLO
|
US |
|
Aditya Birla Fashion and Retail Ltd
BSE:535755
|
IN |
|
Toyoda Gosei Co Ltd
TSE:7282
|
JP |
|
Super Micro Computer Inc
F:MS51
|
US |
|
K
|
KB No.31 Special Purpose Acquisition Co
KOSDAQ:492220
|
KR |
|
E
|
Entropy Neurodynamics Ltd
OTC:TYPTF
|
AU |
|
A
|
Atrys Health SA
F:A2T
|
ES |
|
C
|
China Pacific Insurance Group Co Ltd
SWB:75C
|
CN |
|
H
|
Hexatronic Group AB
DUS:02H0
|
SE |
Multiples-Based Value
The Multiples-Based Value for 
Corvus Pharmaceuticals Inc (C17) under the Base Case is hidden
EUR.
Compared with the current market price of 9.134 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
C17 Multiples-Based Value
LOCKED